This Week in Cancer Research | GenomeWeb

This Week in Cancer Research


In Cancer Research this week, researchers from the City of Hope Comprehensive Cancer Center in California say STAT3 inhibition could work as a therapeutic strategy for activated B-cell-like, diffuse large B-cell lymphoma. Direct inhibition of STAT3 with short hairpin RNA suppressed the growth of human ABC-like diffuse large B-cell lymphoma in mouse models, the authors write.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.